Vicor Technologies, Inc.
(Public, OTC:VCRT) Watch this stockFind more results for
VCRT
Advertisement
Key stats and ratios
| Q2 (Jun '09) | 2008 | |
| Net profit margin | - | - |
| Operating margin | - | - |
| EBITD margin | - | - |
| Return on average assets | -931.58% | -1442.02% |
| Return on average equity | - | - |
| Employees | 7 | - |
Address
2300 Corporate Blvd., N.W., Suite 123
Boca Raton, FL 33431
United States - Map
+1-561-9957313 (Phone)
+1-561-9952449 (Fax)
Boca Raton, FL 33431
United States - Map
+1-561-9957313 (Phone)
+1-561-9952449 (Fax)
Website links
Vicor Technologies, Inc. discussions
View all discussions »Description
Vicor Technologies, Inc. is a medical diagnostics company focused on commercializing noninvasive diagnostic technology products based on its point correlation dimension algorithm (the PD2i Algorithm). As of December 31, 2008, the Company is commercializing four diagnostic medical products, which employs software utilizing the PD2i Algorithim, the PD2i Analyzer, the PD2i-VS (Vital Sign), the PD2i Cardiac Analyzer and the PD2i OR/ICU. The PD2i Analyzer, received 510(k) marketing clearance from the Food and Drug Administration (FDA) on December 29, 2008. The PD2i Analyzer displays and analyzes electrocardiographic (ECG) information that measures heart rate variability (HRV).
Officers and directors
| David H. Fater | President, Chief Executive Officer, Chief Financial Officer, Director | |
| James E. Skinner Ph.D. | Vice President, Director - Grant Research, Director | |
| Jerry M. Anchin Ph.D. | Vice President, Director of Research and Development , Director | |
| Thomas J. Bohannon | Chief Accounting Officer | |
| Daniel N. Weiss M.D. | Chief Medical Officer | |
| Edward Wiesmeier M.D. | Director | |
| Frederick M. Hudson | Director | |
| Joseph A. Franchetti | Director |